Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
AstraZeneca
Boehringer Ingelheim
Mallinckrodt
Argus Health
UBS
US Army
Queensland Health
Dow

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020920

« Back to Dashboard

NDA 020920 describes NATRECOR, which is a drug marketed by Scios Llc and is included in one NDA. It is available from one supplier. Additional details are available on the NATRECOR profile page.

The generic ingredient in NATRECOR is nesiritide recombinant. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nesiritide recombinant profile page.
Summary for 020920
Tradename:NATRECOR
Applicant:Scios Llc
Ingredient:nesiritide recombinant
Patents:0
Pharmacology for NDA: 020920
Ingredient-typeNatriuretic Peptides
Suppliers and Packaging for NDA: 020920
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920 NDA Scios LLC 65847-205 N 65847-205-25

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;INTRAVENOUSStrength1.5MG/VIAL
Approval Date:Aug 10, 2001TE:RLD:Yes

Expired US Patents for NDA 020920

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Scios Llc NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 ➤ Sign Up ➤ Sign Up
Scios Llc NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 ➤ Sign Up ➤ Sign Up
Scios Llc NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cipla
US Army
US Department of Justice
Daiichi Sankyo
Mallinckrodt
Covington
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.